0NR vs ALKS: Side-by-Side Comparison
Compare UNIPHAR PLC EO -08 (0NR) and Alkermes plc (ALKS) side by side: market cap EUR 1.17B vs USD 9.10B, P/E 23.7 vs 60.7. Financials, growth and model signals on Bullrun.
| Metric | 0NR | ALKS |
|---|---|---|
| Company | UNIPHAR PLC EO -08 | Alkermes plc |
| Country / Exchange | Ireland · F | Ireland · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Medical Distribution | Drug Manufacturers-Specialty & Generic |
| Market cap | EUR 1.17B | USD 9.10B |
| P/E ratio | 23.7 | 60.7 |
| Dividend yield | 0.45% | — |
| Valuation model | — | 51.7% overvalued |
| Revenue (FY2025) | EUR 3.07B | USD 1.48B |
| Revenue growth YoY | +11.0% | -5.2% |
| Net income | EUR 51.09M | USD 241.70M |
| Gross margin | 14.9% | 86.7% |
| Diluted EPS | — | 1.43 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.